Ignite Creation Date:
2025-12-24 @ 7:42 PM
Ignite Modification Date:
2025-12-26 @ 12:06 PM
Study NCT ID:
NCT01304303
Status:
COMPLETED
Last Update Posted:
2019-05-03
First Post:
2011-02-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Pharmacokinetic and Safety Study of SPARC1023 Alone and in Carboplatin Combination
Sponsor:
Sun Pharma Advanced Research Company Limited
Organization:
Study Overview
Official Title:
None
Status:
COMPLETED
Status Verified Date:
2019-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Phase I study of SPARC1023 alone and in combination with carboplatin
Detailed Description:
Pharmacokinetic profile and dose escalation study of SPARC1023 when administered as 30-min infusion.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: